With the exception of SKP2 and CDKN1A, expression of each of these genes was significantly elevated in ER+ breast cancers with PRR11 copy number gain/amplification in the METABRIC and TCGA dataset (Supplementary Fig. 4c, d). This evidence concerns the gene SKP2 and breast carcinoma.